Atlas Trials

Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia

Clinical trial NCT05232227 · WITHDRAWN

Trial details

NCT number
NCT05232227
Sponsor
University of California, San Francisco
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Malaria, VivaxRelapse
Start date
2023-01-20
Primary completion
2023-06-05
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.